EC-IC bypass: The failure of a clinical trial? Applicability to PFO closure trials Nancy Futrell OriginalPaper 18 May 2007 Pages: 173 - 179
von Willebrand factor in CHD and stroke: Relationships and therapeutic implications Marie-Therese CooneyAlexandra L. DudinaIan M. Graham OriginalPaper 18 May 2007 Pages: 180 - 190
Role of protein Z in stroke Huyen A. TranJohn W. Eikelboom OriginalPaper 18 May 2007 Pages: 191 - 197
ACE genotype, risk and causal relationship to stroke: Implications for treatment Agnieszka SlowikTomasz DziedzicAndrzej Szczudlik OriginalPaper 18 May 2007 Pages: 198 - 204
The role of angiogenesis in damage and recovery from ischemic stroke Juan F. ArenillasTomás SobrinoAntoni Dávalos OriginalPaper 18 May 2007 Pages: 205 - 212
The difference between a dynamic and mechanical approach to stroke treatment Cathy M. Helgason OriginalPaper 18 May 2007 Pages: 213 - 220
The nature of hand motor impairment after stroke and its treatment Pretti Raghavan OriginalPaper 18 May 2007 Pages: 221 - 228
Carotid plaque, stroke pathogenesis, and CRP: Treatment of ischemic stroke Jerzy KrupinskiMarta M. TuruJosé Martínez-González OriginalPaper 18 May 2007 Pages: 229 - 235
The clinical assessment of retinal microvascular structure and therapeutic implications Alun D. Hughes OriginalPaper 18 May 2007 Pages: 236 - 241
New treatment options for hypertension during acute ischemic or hemorrhagic stroke J. David Spence OriginalPaper 18 May 2007 Pages: 242 - 246